AI and quantum guidance are driving the future of the National Institute of Standards and Technology Cybersecurity Framework.

Spruce Biosciences offers a high-risk, high-reward opportunity as it advances TA-ERT, potentially the first disease-modifying therapy for MPS IIIB, toward FDA approval. TA-ERT demonstrated durable ...

A recent investigation revealed that fish oil supplements do not enhance cognitive performance. In older adults predisposed ...

Cognitive decline in very old adults has been considered for decades to be an almost inevitable consequence of aging. In clinical practice, this has contributed to many memory problems in patients ...

Two years ago, we published a list of 5 predictions about AI in the year 2030. The article sparked a lot of fascinating (and ...

Longevity medicine relies on advanced biomarker analysis to support preventive healthcare and more personalized patient ...

Cognitive decline in very old adults has been considered for decades to be an almost inevitable consequence of aging. In clinical practice, this has ...

Cognitive decline in very old adults has been considered for decades to be an almost inevitable consequence of aging.

Discusses Preliminary Phase II Results for SNT-4728 in Isolated REM Sleep Behavior Disorder July 5, 2026 11:30 PM ...

Circular Genomics today announced the launch of CircPATHtm, the company's proprietary circular RNA discovery and validation engine, following the publication of landmark findings in Nature Medicine ...

Micro- and nanoplastics turned up in essentially every brain tissue sample a research team examined, but the concentrations ...

AlzeCure licensed NeuroRestore ACD856 to QuantumCell in a deal worth over $2.2B. The real story is not proof, but Alzheimer’s ...